MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 66 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,333,000 | -30.0% | 2,976,121 | 0.0% | 0.07% | -5.4% |
| Q4 2021 | $4,762,000 | -33.9% | 2,976,121 | 0.0% | 0.07% | -21.3% |
| Q3 2021 | $7,202,000 | -23.7% | 2,976,121 | 0.0% | 0.09% | -3.1% |
| Q2 2021 | $9,434,000 | -5.9% | 2,976,121 | 0.0% | 0.10% | -2.0% |
| Q1 2021 | $10,030,000 | -5.9% | 2,976,121 | 0.0% | 0.10% | +16.5% |
| Q4 2020 | $10,655,000 | +154.5% | 2,976,121 | +86.2% | 0.08% | +165.6% |
| Q3 2020 | $4,187,000 | +996.1% | 1,598,185 | +1178.9% | 0.03% | +966.7% |
| Q2 2020 | $382,000 | – | 124,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,048,757 | $6,904,000 | 2.75% |
| Asymmetry Capital Management, L.P. | 1,063,264 | $3,583,000 | 1.85% |
| Endurant Capital Management LP | 1,339,835 | $4,515,000 | 1.18% |
| Altium Capital Management LP | 1,250,000 | $4,213,000 | 1.17% |
| Affinity Asset Advisors, LLC | 900,000 | $3,033,000 | 1.03% |
| DAFNA Capital Management LLC | 1,249,648 | $4,211,000 | 1.00% |
| Boxer Capital, LLC | 6,226,673 | $20,984,000 | 0.71% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $865,000 | 0.60% |
| Rubric Capital Management LP | 2,914,861 | $9,823,000 | 0.57% |
| Orbimed Advisors | 17,264,763 | $58,183,000 | 0.54% |